by Rutgers University Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH Animal studies indicate that a new COVID-19 vaccine developed at Rutgers may provide more durable protection...
Tag: <span>COVID vaccine</span>
Post
New research reveals possible COVID vaccine blood clot connection
by Flinders University Graphical abstract. Credit: Cell Reports Medicine (2023). DOI: 10.1016/j.xcrm.2023.100971 A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system. The COVID-19 Vaccine Immune Responses Study (COVIRS), published in Cell Reports Medicine, tracked the immune responses of 102 adults of...
Post
Which COVID vaccine you get could affect your myocarditis risk
by American College of Cardiology Credit: Unsplash/CC0 Public Domain Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases of heart inflammation with either vaccine are very rare, according to a study in...
Post
PFIZER’S JACKING UP THE COVID VACCINE COST TO 10,000 PERCENT ITS PRODUCTION COST
We’re not surprised, just really disappointed. Reuters reports that next year, pharma giant Pfizer plans to nearly quadruple the per-dose price of their COVID-19 vaccine, jacking costs from $20 to $30 per shot to $110 to $130. Particularly striking: Experts, per Reuters, estimate that at that price, the vaccine cost 10,000 times what it costs Pfizer to actually...
Post
AstraZeneca’s COVID vaccine suffers a setback in nasal spray trial
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York, United States Mon, October 10, 2022 at 4:07 PM (Reuters) – Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a...
Post
New generation of COVID vaccine shows promising results
by Karolinska Institutet Credit: Pixabay/CC0 Public Domain Researchers at Karolinska Institutet are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers now hope to be able to take it to...
Post
COVID vaccine patch fights variants better than needles
by University of Queensland A vaccine patch. Credit: The University of Queensland A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using...
Post
University of Washington COVID vaccine effective in test
A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing. SK bioscience, the company leading the vaccine’s clinical development, will seek authorization for its use in South Korea within the month. The Seattle scientists behind the new vaccine sought to create a ‘second-generation’ vaccine for COVID-19...
Post
COVID VACCINE DOES PROTECT PEOPLE WITH IBD
For the study, researchers focused on all studies describing the response of patients with inflammatory bowel disease (IBD) who received a COVID-19 vaccine. People with the disease are commonly treated with drugs that suppress the immune system and have reported concerns over whether such treatments might weaken their response to the vaccine. “We wanted to demonstrate in...
Post
Protein subunit COVID vaccine, which can be manufactured using engineered yeast, shows promise in preclinical studies
by Massachusetts Institute of Technology Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH While many people in wealthier countries have been vaccinated against COVID-19, there...